BNP Paribas Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-345,791
| Closed | -$9.28M | – | 957 |
|
|
2022
Q1 | $9.28M | Sell |
345,791
-29,119
| -8% | -$782K | 0.03% | 424 |
|
|
2021
Q4 | $17.9M | Buy |
374,910
+7,829
| +2% | +$373K | 0.06% | 340 |
|
|
2021
Q3 | $24.4M | Buy |
367,081
+64,503
| +21% | +$4.28M | 0.09% | 255 |
|
|
2021
Q2 | $23.6M | Buy |
302,578
+79,647
| +36% | +$6.21M | 0.08% | 277 |
|
|
2021
Q1 | $21.1M | Sell |
222,931
-45,160
| -17% | -$4.27M | 0.09% | 271 |
|
|
2020
Q4 | $32.7M | Sell |
268,091
-5,480
| -2% | -$668K | 0.15% | 171 |
|
|
2020
Q3 | $23.9M | Buy |
273,571
+53,987
| +25% | +$4.72M | 0.14% | 186 |
|
|
2020
Q2 | $14.2M | Buy |
+219,584
| New | +$14.2M | 0.1% | 241 |
|